Company - Intellectual Property

Uscom is an innovative Australian Medical Device Company with novel methods and approaches for measuring and monitoring cardiovascular performance. These methods and approaches are important for the improvement of clinical practice and form an important part of the value of the Company. These methods and approaches will be legally protected to optimise their value to the Company.

Intellectual Property is important to Uscom

• Uscom believes in the value of Intellectual Property to shareholders
• Uscom encourages creative and novel science
• Uscom uses the legal system to protect this Intellectual Property, and actively manages an international Intellectual Property portfolio
• We believe new and useful products will result from this investment

Uscom firmly believes in the value of Intellectual Property (IP) and has actively developed and protected new concepts and science which will form the foundation for future products. Uscom continues to accumulate a portfolio of IP based around its core cardiac monitoring patent and other approaches to cardiovascular monitoring and measurement.

Uscom's first patent application was filed in June 1998 and related to the core Uscom concept. The patent was subsequently filed internationally in June 1999. This consists of a primary claim and 10 attendant claims relating to the transcutaneous monitoring of intra-cardiac flow.
In June 2000 the IPER (International Preliminary Examination Report) was issued, stating that all of the claims were novel, inventive and with industrial applicability. Uscom's technology is initially protected worldwide under the IPER "patent pending" provisions and then proceeds to Market Entry Phase in strategically selected national markets around the world.
National Market Entry Phase for the core Uscom patent has been completed for Australia, the United States and Europe. Uscom has two additional patents granted in Australia and the US, and has approximately 30 patent cases currently proceeding through the international patent recognition system.

Uscom's patent portfolio, currently relating to 30 different applications, has been developed to support the core Uscom patent and to establish protection for novel methods and approaches to cardiovascular monitoring which will form the foundation for development of future products and new product platforms.